反応式
[Br:1][C:2]1[C:3]([S:19][CH:20]([CH2:24][CH3:25])[C:21](=[O:23])[CH3:22])=[N:4][C:5]([NH:8][C:9]2[CH:10]=[CH:11][C:12]([S:15]([NH2:18])(=[O:17])=[O:16])=[N:13][CH:14]=2)=[N:6][CH:7]=1.[BH4-].[Na+]>C1COCC1.CO.C(O)(=O)C>[Br:1][C:2]1[C:3]([S:19][CH:20]([CH2:24][CH3:25])[CH:21]([OH:23])[CH3:22])=[N:4][C:5]([NH:8][C:9]2[CH:10]=[CH:11][C:12]([S:15]([NH2:18])(=[O:17])=[O:16])=[N:13][CH:14]=2)=[N:6][CH:7]=1参加物
5
反応物 2
生成物 1
試薬・触媒・溶媒 2
実験手順
26 mg (0.058 mmol) of 5-[5-bromo-4-(1-ethyl-2-oxo-propylsulfanyl)-pyrimidin-2-ylamino]-pyridine-2-sulfonic acid amide, dissolved in 1.5 ml of THF/MeOH 1:1, is mixed with 10 mg of sodium borohydride and stirred for 3 hours at room temperature. While being cooled, 2-3 drops of glacial acetic acid are added and concentrated by evaporation. Uptake in acetonitrile and suctioning-off yield 17 mg (65% of theory) of 5-[5-bromo-4-(1-ethyl-2-hydroxy-propylsulfanyl)-pyrimidin-2-ylamino]-pyridine-2-sulfonic acid amide.
後処理
- temperatureWhile being cooled
- concentrationconcentrated by evaporation
出典と根拠
- ORDレコード
- ord-8fe3323d05b246749d496264ffd29609
- 出典データセット
- uspto-grants-2007_10
- 特許番号
- US07288547B2
関連ノート
読み込み中…